Current status and prospect of treatments for recurrent hepatocellular carcinoma

Table 1 Overall survival and recurrence-free survival after re-resection for hepatocellular carcinoma recurrence

Ref.	Type	Year	n	1-, 3-, and 5-yr OS	1-, 3-, and 5-yr RFS
Huang et al[83]	Retrospective	1995-2010	82	71%/41%/22%	N/A
Itamoto et al[168]	Retrospective	1990-2004	84	88%/67%/50%	-/-/10%
Li et al[169]	Retrospective	1997-2015	103	92%/-/54%	N/A
Lu et al[81]	Retrospective	2004-2015	138	92%/82%/73%	N/A
Ho et al[103]	Retrospective	2001-2007	54	90%/-/72%	N/A
Sun et al[170]	Retrospective	1997-2003	57	70%/61%/31%	N/A
Wang et al[104]	Retrospective	2004-2010	128	98%/84%/64%	95%/72%/43%
Roayaie et al[171]	Retrospective	1994-2009	35	-/-/67%	-/55%/-
Faber et al[80]	Retrospective	1990-2009	27	96%/70%/42%	70%/46%/30%
Liu et al[87]	Retrospective	2008-2015	30	97%/85%/75%	79%/46%/30%
Sun et al[172]	Retrospective	2002-2014	43	98%/83%/56%	57%/32%/29%
Song et al[173]	Retrospective	1994-2012	39	89%/89%/84%	66%/49%/43%
Chan et al[93]	Retrospective	2001-2008	45	90%/57%/35%	41%/24%/24%

OS: Overall survival; RFS: Recurrence-free survival; HCC: Hepatocellular carcinoma; N/A: Not applicable.